Clinical Trials in Pittsburgh

Showing 4341-4360 of 16,007 trials

A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant

NCT05109195

The purpose of this study is to assess the safety (adverse events, serious adverse events, deaths, suicidality) of participants with major depressive disorder (MDD) treated according to the standard of care (SOC).

Depressive Disorder, Major

Janssen Research & Development, LLC7 participantsStarted Oct 2021

San Francisco, California, United States • Boston, Massachusetts, United States • Pittsburgh, Pennsylvania, United States +1 more locations

TERMINATEDPhase 313 miles

A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus

NCT03517722

The purpose of this study is to evaluate the efficacy of ustekinumab in participants with active systemic lupus erythematosus (SLE) who have not adequately responded to one or more standard of care treatments.

Lupus Erythematosus, Systemic

Janssen Research & Development, LLC516 participantsStarted Apr 2018

Anniston, Alabama, United States • Birmingham, Alabama, United States • Vestavia Hills, Alabama, United States +201 more locations

A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant

A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus

Find Trials by Condition in Pittsburgh

A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder

The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older

Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients

An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease

A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression

A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

Chronic Pain in Rheumatoid Arthritis

A Study of Suboptimally Controlled Participants Previously Taking Injectable DMDs for RMS (CLICK-MS)

A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep Apnea

Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck

A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation

APX005M and Doxorubicin in Advanced Sarcoma

Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)